Who is sponsoring NCT06589934?

NCT06589934 is sponsored by Philips Clinical & Medical Affairs Global.

What drugs are being tested in NCT06589934?

Interventions in NCT06589934: Precise Image.

What condition does NCT06589934 study?

NCT06589934 studies Precise Image (AI Reconstruction Feature of CT 5400 RT System).

Is NCT06589934 still recruiting?

NCT06589934 is currently completed. Last updated 25 November 2025.

Last reviewed 2025-11-25 · How we verify

NCT06589934

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Clinical Study of CT 5400 RT for Precise Image Validation

Completed NA Last updated 25 November 2025

What this trial tests

NA trial testing Precise Image in Precise Image (AI Reconstruction Feature of CT 5400 RT System) in 30 participants. Completed in 25 March 2025.

Timeline

25 January 2025

Primary endpoint
25 January 2025

25 March 2025

Quick facts

Lead sponsor	Philips Clinical & Medical Affairs Global
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	diagnostic
Enrollment	30
Start date	25 January 2025
Primary completion	25 January 2025
Estimated completion	25 March 2025
Sites	1 location across China

Drugs / interventions tested

Precise Image

Conditions studied

Precise Image (AI Reconstruction Feature of CT 5400 RT System) — all drugs for Precise Image (AI Reconstruction Feature of CT 5400 RT System) →

Sponsor

Philips Clinical & Medical Affairs Global — full company profile →

Who can join

Adults 18 to 75, any sex, with Precise Image (AI Reconstruction Feature of CT 5400 RT System). Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this study is to evaluate the effectiveness of the Precise Image (PI), an AI feature of CT 5400 RT System

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Philips Clinical & Medical Affairs Global trials

Trials by the same sponsor.

NCT07521735 — NEXT GEN - PHILIPS OPTIMUS · recruiting
NCT07368036 — MR 7700 Multinuclear Application Clinical Trial · NA · not yet recruiting
NCT07449715 — Respiration From Pleth Validation · recruiting
NCT07317479 — Clinical Study for P-MAR · not yet recruiting
NCT07317427 — Precise Image for Interventional CT · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06589934 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Philips Clinical & Medical Affairs Global
Last refreshed: 25 November 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06589934.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing